Healiva® Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew
apnews.com
tech
2022-06-01 06:32:27

LUGANO, Switzerland--(BUSINESS WIRE)--Jun 1, 2022--Healiva ®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® to establish one of the world's broadest portfolios of affordable, personalized, end-to-end wound care consisting of enzyme technology, autologous & allogenic cell therapies, and medical devices.
